The Gamalei Center called the timing of the creation of a personalized oncology vaccine
Creating a personalized mRNA vaccine for a cancer patient takes about two to three months, Director of the Gamalei Center, member of the scientific committee of the Challenge Prize Denis Logunov told Science Mail.

Creating a personalized mRNA vaccine for a cancer patient takes about two to three months, Director of the Gamalei Center, member of the scientific committee of the Challenge Prize Denis Logunov told Science Mail.
First, a biopsy is taken from the patient, after which experts sequence the genomes of the tumor and normal tissue. They are compared to identify changes that have occurred in tumor cells.
Genome sequencing is the process of accurately reading and deciphering the genetic code recorded in DNA.
“We have to read the tumor genome and the normal genome. And, comparing the genome of the tumor and the genome of the norm, we should see these breakdowns, explained Logunov.
Then special algorithms, including those based on artificial intelligence, determine which of the identified changes can be recognized by cellular immunity. Based on the selected changes, a design is created that is encoded by mRNA.
Once administered, mRNA should help the immune system focus the response on the characteristic features of a particular patient's tumor. The need to go through all the stages distinguishes a personalized vaccine from a drug that is produced in advance for a large group of people.
In April, the first patient received a personalized anti-tumor mRNA vaccine "Neonkovak" for the treatment of skin melanoma at the NMIC radiology. The drug was developed jointly with the Gamalea Center. The vaccine is made individually for each patient, it must adjust the immune system to recognize and destroy tumor cells.



